Since PLD2 regulates nuclear ERK activity in several cancer cell lines92 it is not surprising that proliferation of prostate cell lines and patient-derived PCa cells is effectively inhibited by JWJ (Fig. 5a, b). This evidence concerns the gene PLD2 and urogenital neoplasm.